Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. (CMRA): 2 pipeline candidates · ~3 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
3.2 months
D/E -0.70 · 0% dilution
N/A
2 candidates
N/A
N/A
A transparent, data-derived signal for Comera Life Sciences Holdings, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$3K
Cash
$1.8M
Quarterly Burn
$1.9M
Runway
3.2 mo
Revenue
$136K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| Caffeine-based SQore excipient | — |
| CLS-001 | — |
Institutional Holdings
Source: SEC Form 13F · as of Sep 2023Institutional holders
15
Total value held
$207K
| Holder | Shares | Value |
|---|---|---|
| corient private wealth llc | 493,692 | $123K |
| vanguard group inc | 88,196 | $26K |
| geode capital management, llc | 70,212 | $22K |
| hightower advisors, llc | 47,600 | $14K |
| state street corp | 29,600 | $9K |
| citadel advisors llc | 17,458 | $6K |
| ubs group ag | 8,017 | $2K |
| tower research capital llc (trc) | 7,338 | $2K |
| osaic holdings, inc. | 3,600 | $1K |
| morgan stanley | 2,292 | $668 |
Showing top 10 of 15 institutional holders of Comera Life Sciences Holdings, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Comera Life Sciences Holdings, Inc.'s pipeline?
Comera Life Sciences Holdings, Inc. (CMRA) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Comera Life Sciences Holdings, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Comera Life Sciences Holdings, Inc. has approximately 3.2 months of cash runway.
What is Comera Life Sciences Holdings, Inc.'s market capitalization?
Comera Life Sciences Holdings, Inc.'s market capitalization is approximately $3K.
Who is the CEO of Comera Life Sciences Holdings, Inc.?
Mr. Michael G. Campbell CPA is the chief executive officer of Comera Life Sciences Holdings, Inc. (CMRA).
Get the full picture on Comera Life Sciences Holdings, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.